Corrigendum to “The role of H3K4me3 and H3K9/14ac in the induction by dexamethasone of Per1 and Sgk1, two glucocorticoid early response genes that mediate the effects of acute stress in mammals” [Biochimica et Biophysica Acta - Gene Regulatory Mechanisms 1839 (2014) 866–872](S1874939914001990)(10.1016/j.bbagrm.2014.07.011);The role of H3K4me3 and H3K9/14ac in the induction by dexamethasone of Per1 and Sgk1, two glucococorticoid early response genes that mediate the effects of acute stress in mammals

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1839, Issue 9, 2014, Pages 866-872

  Xydous, M ^a   Prombona, A ^a   Sourlingas, T G ^a  

^a INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

Author keywords

Acute stress; Glucocorticoid early response gene; Histone H3 post translational modification; Nicotinamide; Per1 core clock gene; Sgk1

Indexed keywords

DEXAMETHASONE; HISTONE H3; LYSINE; NICOTINAMIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; PER1 PROTEIN; RNA; SERUM AND GLUCOCORTICOID REGULATED KINASE 1; SIRTINOL; SIRTUIN; THYMIDINE;

3T3 CELL LINE; ACUTE STRESS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CHRONIC STRESS; CONTROLLED STUDY; EARLY RESPONSE GENE; ENZYME INHIBITION; HISTONE MODIFICATION; MOUSE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; ROLE PLAYING;

ACUTE STRESS; GLUCOCORTICOID EARLY RESPONSE GENE; HISTONE H3 POST-TRANSLATIONAL MODIFICATION; NICOTINAMIDE; PER1 CORE CLOCK GENE; SGK1;

ANIMALS; CELL LINE, TUMOR; DEXAMETHASONE; GENES, IMMEDIATE-EARLY; HISTONES; IMMEDIATE-EARLY PROTEINS; MICE; NIACINAMIDE; NIH 3T3 CELLS; PERIOD CIRCADIAN PROTEINS; PROMOTER REGIONS, GENETIC; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN-SERINE-THREONINE KINASES; RESPONSE ELEMENTS; STRESS, PHYSIOLOGICAL; TRANSCRIPTIONAL ACTIVATION;

EID: 84905377196     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2017.01.011     Document Type: Erratum

References (56)

1. Chrousos G.P. Glucocorticoid therapy. Endocrinology and Metabolism 2001, 609-632. McGraw-Hill, New York. fourth ed. P. Felig, L. Frohman (Eds.).
2. Franchimont D., Kino T., Galon J., Meduri G.U., Chrousos G.P. Glucocorticoids and inflammation revisited: the state of the art. Neuroimmunomodulation 2002, 10:247-260. 10.1159/000069969.
3. Giguere V., Hollenberg S.M., Rosenfeld M.G., Evans R.M. Functional domains of the human glucocorticoid receptor. Cell 1986, 46:645-652. 10.1016/0092-8674(86)90339-9.
4. Hollenberg S.M., Evans R.M. Multiple and cooperative trans-activation domains of the human glucocorticoid receptor. Cell 1988, 55:899-906. 10.1016/0092-8674(88)90145-6.
5. Dahlman-Wright K., Baumann H., McEwan I.J., Almlöf T., Wright A.P., Gustafsson J.A., Härd T. Structural characterization of a minimal functional transactivation domain from the human glucocorticoid receptor. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:1699-1703. ([PMC Free Article]).
6. Beato M., Truss M., Chavez S. Control of transcription by steroid hormones. Ann. N. Y. Acad. Sci. 1996, 784:93-123. 10.1111/j.1749-6632.1996.tb16231.x.
7. Galon J., Franchimont D., Hiroi N., Frey G., Boettner A., Ehrhart-Bornstein M., O'Shea J.J., Chrousos G.P., Bornstein S.R. Gene profiling reveals unknown enhancing and suppressive actions of glucocorticoids on immune cells. FASEB J. 2002, 16:61-71. 10.1096/fj.01-0245com.
8. Tsai C.C., Fondell J.D. Nuclear receptor recruitment of histone-modifying enzymes to target gene promoters. Vitam. Horm. 2004, 68:93-122. 10.1016/S0083-6729(04)68003-4.
9. Green C.D., Han J.D. Epigenetic regulation by nuclear receptors. Epigenomics 2011, 3:59-72. 10.2217/epi.10.75.
10. Waldegger S., Barth P., Raber G., Lang F. Cloning and characterization of a putative human serine/threonine protein kinase transcriptionally modified during anisotonic and isotonic alterations of cell volume. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:4440-4445. ([PMC Free Article]).
11. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., Zhang J., Soden R., Hayakawa M., Kreiman G., Cooke M.P., Walker J.R., Hogenesch J.B. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:6062-6067. 10.1073/pnas.0400782101.
12. Rusak B., Zucker I. Neural regulation of circadian rhythms. Physiol. Rev. 1979, 59:449-526. ([Free Article]).
13. Meijer J.H., Rietveld W.J. Neurophysiology of the suprachiasmatic circadian pacemaker in rodents. Physiol. Rev. 1989, 69:671-707. ([Free Article]).
14. Ralph M.R., Foster R.G., Davis F.C., Menaker M. Transplanted suprachiasmatic nucleus determines circadian period. Science 1990, 247:975-978. 10.1126/science.2305266.
15. Silver R., LeSauter J., Tresco P.A., Lehman M.N. A diffusible coupling signal from the transplanted suprachiasmatic nucleus controlling circadian locomotor rhythms. Nature 1996, 382:810-813. 10.1038/382810a0.
16. Balsalobre A., Brown S.A., Marcacci L., Tronche F., Kellendonk C., Reinchardt H.M., Schutz G., Schibler U. Resetting of circadian time in peripheral tissues by glucocorticoid signalling. Science 2000, 289:2344-2347. 10.1126/science.289.5488.2344.
17. Yoo S.H., Yamazaki S., Lowrey P.L., Shimomura K., Ko C.H., Buhr E.D., Siepka S.M., Hong H.K., Oh W.J., Yoo O.J., Menaker M., Takahashi J.S. PERIOD2::LUCIFERASE real-time reporting of circadian dynamics reveals persistent circadian oscillations in mouse peripheral tissues. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:5339-5346. 10.1073/pnas.0308709101.
18. Lang F., Böhmer C., Palmada M., Seebohm G., Strutz-Seebohm N., Vallon V. (Patho)physiological significance of the serum- and glucocorticoid-inducible kinase isoforms. Physiol. Rev. 2006, 86:1151-1178.
19. Anacker C., Cattaneo A., Musaelyan K., Zunszain P.A., Horowitz M., Molteni R., Luoni A., Calabrese F., Tansey K., Gennarelli M., Thuret S., Price J., Uher R., Riva M.A., Pariante C.M. Role for the kinase SGK1 in stress, depression, and glucocorticoid effects on hippocampal neurogenesis. Proc. Natl. Acad. Sci. U. S. A. 2013, 110:8708-8713. 10.1073/pnas.1300886110.
20. Yamamoto T., Nakahata Y., Tanaka M., Yoshida M., Soma H., Shinohara K., Yasuda A., Mamine T., Takumi T. Acute physical stress elevates mouse period1 mRNA expression in mouse peripheral tissues via a glucocorticoid-responsive element. J. Biol. Chem. 2005, 280:42036-42043. 10.1074/jbc.M509600200.
21. Yuen E.Y., Liu W., Karatsoreos I.N., Ren Y., Feng J., McEwen B.S., Yan Z. Mechanisms for acute stress-induced enhancement of glutamatergic transmission and working memory. Mol. Psychiatry 2011, 16:156-170. 10.1038/mp.2010.50.
22. Möhler H., Polc P., Cumin R., Pieri L., Kettler R. Nicotinamide is a brain constituent with benzodiazepine-like actions. Nature 1979, 278:563-565. 10.1038/278563a0.
23. Paul S.M., Marangos P.J., Skolnick P., Goodwin F.K. Biological substrates of anxiety: benzodiazepine receptors and endogenous ligands. Encéphale 1982, 8:131-144.
24. Akhundov R.A., Sultanov A.A., Gadzhily R.A., Sadykhov R.V. Psychoregulating role of nicotinamide. Bull. Exp. Biol. Med. 1993, 115:529-533. ([Free Article]).
25. Xydous M., Sekeri-Pataryas K.E., Prombona A., Sourlingas T.G. Nicotinamide treatment reduces the levels of histone H3K4 trimethylation in the promoter of the mPer1 circadian clock gene and blocks the ability of dexamethasone to induce the acute response. Biochim. Biophys. Acta 2012, 1819:877-884. 10.1016/j.bbagrm.2012.03.001.
26. Webster M.K., Goya L., Ge Y., Maiyar A.C., Firestone G.L. Characterization of sgk, a novel member of the serine/threonine protein kinase gene family which is transcriptionally induced by glucocorticoids and serum. Mol. Cell. Biol. 1993, 13:2031-2040. ([PMC Free Article]).
27. Webster M.K., Goya L., Firestone G.L. Immediate-early transcriptional regulation and rapid mRNA turnover of a putative serine/threonine protein kinase. J. Biol. Chem. 1993, 268:11482-11485. ([Free Article]).
28. Strahl B.D., Ohba R., Cook R.G., Allis C.D. Methylation of histone H3 at lysine 4 is highly conserved and correlates with transcriptionally active nuclei in Tetrahymena. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:14967-14972. ([PMC Free Article]).
29. Wang H., Cao R., Xia L., Erdjument-Bromage H., Borchers C., Tempst P., Zhang Y. Purification and functional characterization of a histone H3 lysine 4-specific methyltransferase. Mol. Cell 2001, 8:1207-1217. 10.1016/S1097-2765(01)00405-1.
30. Santos-Rosa H., Schneider R., Bannister A.J., Sherriff J., Bernstein B.E., Emre N.C., Schreiber S.L., Mellor J., Kouzarides T. Active genes are tri-methylated at K4 of histone H3. Nature 2002, 419:407-411. 10.1038/nature01080.
31. Pray-Grant M.G., Daniel J.A., Schieltz D., Yates J.R., Grant P.A. Chd1 chromodomain links histone H3 methylation with SAGA- and SLIK-dependent acetylation. Nature 2005, 433:434-438. 10.1038/nature03242.
32. Sims R.J., Chen C.F., Santos-Rosa H., Kouzarides T., Patel S.S., Reinberg D. Human but not yeast CHD1 binds directly and selectively to histone H3 methylated at lysine 4 via its tandem chromodomains. J. Biol. Chem. 2005, 280:41789-41792. ([PMC Free Article]).
33. Barski A., Cuddapah S., Cui K., Roh T.Y., Schones D.E., Wang Z., Wei G., Chepelev I., Zhao K. High-resolution profiling of histone methylations in the human genome. Cell 2007, 129:823-837. 10.1016/j.cell.2007.05.009.
34. Koch C.M., Andrews R.M., Flicek P., Dillon S.C., Karaöz U., Clelland G.K., Wilcox S., Beare D.M., Fowler J.C., Couttet P., James K.D., Lefebvre G.C., Bruce A.W., Dovey O.M., Ellis P.D., Dhami P., Langford C.F., Weng Z., Birney E., Carter N.P., Vetrie D., Dunham I. The landscape of histone modifications across 1% of the human genome in five human cell lines. Genome Res. 2007, 17:691-707. 10.1101/gr.5704207.
35. Preiss J., Schlaeger R., Hilz H. Specific inhibition of poly ADP ribose polymerase by thymidine and nicotinamide in HeLa cells. FEBS Lett. 1971, 19:244-246. 10.1016/0014-5793(71)80524-0.
36. Rankin P.W., Jacobson E.I., Benjamin R.C., Moss J., Jacobson M. Quantitative studies of inhibitors of ADP-ribosylation in vitro and in vivo. J. Biol. Chem. 1989, 264:4312-4317. ([Free]).
37. Grozinger C.M., Chao E.D., Blackwell H.E., Moazed D., Schreiber S.L. Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening. J. Biol. Chem. 2001, 276:38837-38843. 10.1074/jbc.M106779200.
38. Rudic R.D., McNamara P., Curtis A.M., Boston R.C., Panda S., Hogenesch J.B., Fitzgerald G.A. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol. 2004, 2:e377. 10.1371/journal.pbio.0020377.
39. Lamia K.A., Storch K.F., Weitz C.J. Physiological significance of a peripheral tissue circadian clock. PNAS 2008, 105:15172-15177. 10.1073/pnas.0806717105.
40. Takahashi K., Yamada T., Tsukita S., Kaneko K., Shirai Y., Munakata Y., Ishigaki Y., Imai J., Uno K., Hasegawa Y., Sawada S., Oka Y., Katagiri H. Chronic mild stress alters circadian expressions of molecular clock genes in the liver. AJP Endocrinol. Metab. 2013, 304:301-309. 10.1152/ajpendo.00388.2012.
41. So A.Y., Bernal T.U., Pillsbury M.L., Yamamoto K.R., Feldmana B.J. Glucocorticoid regulation of the circadian clock modulates glucose homeostasis. PNAS 2009, 106:17582-17587. 10.1073/pnas.0909733106.
42. Yuen E.Y., Liu W., Karatsoreos I.N., Feng J., McEwen B.S., Yan Z. Acute stress enhances glutamatergic transmission in prefrontal cortex and facilitates working memory. PNAS 2009, 106:14075-14079. 10.1073/pnas.0906791106.
43. Etchegaray J.P., Lee C., Wade P., Reppert S.M. Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature 2003, 421:177-182. 10.1038/nature01314.
44. Curtis A.M., Seo S.B., Westgate E.J., Rudic R.D., Smyth E.M., Chakravarti D., FitzGerald G.A., McNamara P. Histone acetyltransferase-dependent chromatin remodeling and the vascular clock. J. Biol. Chem. 2004, 279:7091-7097. 10.1074/jbc.M311973200.
45. Naruse Y., Oh-hashi K., Iijima N., Naruse M., Yoshioka H., Tanaka M. Circadian and light-induced transcription of clock gene Per1 depends on histone acetylation and deacetylation. Mol. Cell. Biol. 2004, 14:6278-6287. 10.1128/MCB.24.14.6278-6287.2004.
46. Ripperger J.A., Schibler U. Rhythmic CLOCK-BMAL1 binding to multiple E-box motifs drives circadian Dbp transcription and chromatin transitions. Nat. Genet. 2006, 38:369-374. 10.1038/ng1738.
47. Katada S., Sassone-Corsi P. The histone methyltransferase MLL1 permits the oscillation of circadian gene expression. Nat. Struct. Mol. Biol. 2010, 17:1414-1421. 10.1038/nsmb.1961.
48. Nishioka K., Chuikov S., Sarma K., Erdjument-Bromage H., Allis C.D., Tempst P., Reinberg D. SET9, a novel histone H3 methyltransferase that facilitates transcription by precluding histone tail modifications required for heterochromatin formation. Genes Dev. 2002, 16:479-489. 10.1101/gad.967202.
49. Maltby V.E., Martin B.J., Brind'Amour J., Chruscicki A.T., McBurney K.L., Schulze J.M., Johnson I.J., Hills M., Hentrich T., Kobor M.S., Lorincz M.C., Howe L.J. Histone H3K4 demethylation is negatively regulated by histone H3 acetylation in Saccharomyces cerevisiae. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:18505-18510. 10.1073/pnas.1202070109.
50. Aoyagi S., Archer T.K. Nicotinamide uncouples hormone-dependent chromatin remodeling from transcription complex assembly. Mol. Cell. Biol. 2008, 28:30-39. 10.1128/MCB.01158-07.
51. Lang F., Stournaras C. Serum and glucocorticoid inducible kinase, metabolic syndrome, inflammation, and tumor growth. Hormones (Athens) 2013, 12:160-171. ([Free]).
52. Niren N.M. Pharmacologic doses of nicotinamide in the treatment of inflammatory skin conditions: a review. Cutis 2006, 77:11-16.
53. Surjana D., Damian D.L. Nicotinamide in dermatology and photoprotection. Skinmed 2011, 9:360-365. ([Free]).
54. Zhang X.M., Jing Y.P., Jia M.Y., Zhang L. Negative transcriptional regulation of inflammatory genes by group B3 vitamin nicotinamide. Mol. Biol. Rep. 2012, 39:10367-10371. 10.1007/s11033-012-1915-2.
55. Maiese K., Chong Z.Z., Shang Y.C., Hou J., Wang S. The vitamin nicotinamide: translating nutrition into clinical care. Molecules 2009, 14:3446-3485. 10.3390/molecules14093446.
56. Maiese K., Chong Z.Z., Shang Y.C., Wang S. Novel directions for diabetes mellitus drug discovery. Expert Opin. Drug Discovery 2013, 8:35-48. 10.1517/17460441.2013.736485.